{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:15:27Z","timestamp":1779290127199,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1136\/annrheumdis-2012-201638","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T01:10:29Z","timestamp":1340845829000},"page":"1865-1867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study"],"prefix":"10.1016","volume":"71","author":[{"given":"Elizabeth V","family":"Arkema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald F","family":"van Vollenhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201638_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2007.11.013","article-title":"The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases","volume":"30","author":"Boren","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1136\/annrheumdis-2012-201638_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.med.080708.082655","article-title":"Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies","volume":"61","author":"Major","year":"2010","journal-title":"Annu Rev Med"},{"issue":"Suppl 3","key":"10.1136\/annrheumdis-2012-201638_bib3","doi-asserted-by":"crossref","first-page":"iii64","DOI":"10.1136\/ard.2008.097972","article-title":"Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies","volume":"67","author":"Calabrese","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201638_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrneurol.2011.1","article-title":"Monoclonal antibody therapy-associated neurological disorders","volume":"7","author":"Bosch","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1136\/annrheumdis-2012-201638_bib5","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1136\/annrheumdis-2012-201638_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.23171","article-title":"The effects of rituximab on immunocompetency in patients with autoimmune disease","volume":"58","author":"Looney","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201638_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00228-009-0739-z","article-title":"Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents","volume":"66","author":"Piccinni","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1136\/annrheumdis-2012-201638_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","article-title":"Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis","volume":"68","author":"Clifford","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1136\/annrheumdis-2012-201638_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ard.2010.133371","article-title":"Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden","volume":"70","author":"Neovius","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201638_bib10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.2010.136812","article-title":"How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?","volume":"70","author":"Neovius","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201638_bib11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/ard.2010.130914","article-title":"Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register","volume":"70","author":"Neovius","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201638_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","article-title":"Confidence intervals for directly standardized rates: a method based on the gamma distribution","volume":"16","author":"Fay","year":"1997","journal-title":"Stat Med"},{"key":"10.1136\/annrheumdis-2012-201638_bib13","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.0b013e3181f73600","article-title":"Incidence of progressive multifocal leukoencephalopathy in patients without HIV","volume":"75","author":"Amend","year":"2010","journal-title":"Neurology"},{"key":"10.1136\/annrheumdis-2012-201638_bib14","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","article-title":"Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases","volume":"60","author":"Molloy","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201638_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/BOR.0b013e3282f4b392","article-title":"The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis","volume":"20","author":"Askling","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201638_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201638_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724186396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:03:03Z","timestamp":1737248583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724186396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0003496724186396"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201638","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}